The South Korea anxiety disorder and depression market was valued at USD 142.10 Million in 2024 and is expected to grow at a CAGR of 4.20%, reaching USD 214.42 Million by 2034. The market is experiencing growth due to increasing prevalence of mental health disorders and rising adoption of antidepressant therapies.

Snapshot img

Treatment Resistant Depression Therapeutics Market Size 2025-2029

The treatment resistant depression therapeutics market size is forecast to increase by USD 2.06 billion at a CAGR of 6.1% between 2024 and 2029.

The market is experiencing significant growth due to the high prevalence of mental health disorders, such as depression, in the US population. The emergence of advanced technologies, like artificial intelligence, in drug development is also driving pipeline development in this market. However, the high cost of treatment remains a major challenge, leading to a need for innovative solutions. Combination therapy and somatic therapies are gaining popularity as effective treatment options for those with treatment-resistant depression. Clinical guidelines recommend these approaches for patients who have not responded to traditional antidepressant medications. Furthermore, the market is witnessing an increase in the number of patent filings for new treatment modalities, providing opportunities for pharmaceutical companies to expand their offerings. The market is particularly relevant to individuals suffering from chronic conditions, such as fibromyalgia and chronic pain, who often experience depression as a co-occurring condition. Overall, the market is poised for growth, with a focus on developing effective and affordable treatment options for those in need.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market represents a significant challenge in mental health care due to the limited efficacy of current antidepressant medications for individuals experiencing major depressive episodes. TRD, also known as treatment-resistant major depression, is a subtype of major depressive disorder (MDD) that does not respond to two or more trials of adequate doses of antidepressant medications of appropriate classes. TRD is a complex condition that often results in poor treatment adherence, increased healthcare utilization, and higher risk for hospitalization, suicidal ideation, and psychotic symptoms. According to the Anxiety and Depression Association of America, approximately one-third of individuals diagnosed with MDD experience TRD, making it a critical area of focus for drug development. Pharmacological treatment remains the primary approach for managing TRD. Antidepressants, which are typically administered through oral, intravenous, or nasal routes, have shown limited success in treating TRD. However, recent advancements in TRD therapeutics include the use of esketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, which is administered nasally. Esketamine has shown promising results in clinical trials, providing rapid and sustained antidepressant effects in TRD patients. Despite these advancements, there is a need for alternative treatment approaches to address the complexities of TRD. Nonpharmacological treatments, such as electroconvulsive therapy (ECT), psychotherapy, and transcranial magnetic stimulation, have shown potential in managing TRD.
Combination therapies, which involve the use of multiple treatment modalities, are also being explored to improve treatment outcomes. The market is witnessing a steady product pipeline, with several drugs in various stages of development. These drugs target various mechanisms involved in TRD, including neuroplasticity, neuroinflammation, and neurotransmission. Drug approval processes are ongoing, and successful approvals could significantly impact the market. Mental health disorders, including TRD, have a substantial impact on healthcare access and suicide statistics. According to the National Institute of Mental Health, suicide is the 10th leading cause of death in the US, with depression being a significant risk factor.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Distribution Channel

  Offline
  Online


Type

  Antidepressants
  NMDA
  Antipsychotics
  Others


Geography

  North America

    US


  Europe

    Germany
    UK
    France
    Spain


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Distribution Channel Insights

The offline segment is estimated to witness significant growth during the forecast period.

Treatment-resistant depression (TRD) is a significant challenge in healthcare access, affecting a substantial number of individuals with major depressive disorders and other depression subtypes, including generalized anxiety disorder. According to statistics, suicide is a tragic consequence for some patients with TRD who do not respond to traditional antidepressant therapies. To address this unmet medical need, the product pipelin

Voice Biomarkers for Mental Health Market Outlook

According to our latest research, the Global Voice Biomarkers for Mental Health market size was valued at $312 million in 2024 and is projected to reach $1.46 billion by 2033, expanding at a robust CAGR of 18.7% during 2024–2033. The primary growth driver for this market is the growing demand for non-invasive, scalable, and objective mental health assessment tools, leveraging advances in artificial intelligence and digital health technologies. As mental health disorders become more prevalent globally, the need for early detection and continuous monitoring solutions has never been higher. Voice biomarkers are emerging as a promising frontier, enabling clinicians and researchers to detect subtle changes in voice patterns associated with various mental health conditions, thereby revolutionizing traditional diagnostic approaches and enhancing patient outcomes.

Regional Outlook

North America currently holds the largest share of the global Voice Biomarkers for Mental Health market, accounting for approximately 42% of total revenue in 2024. This dominance is attributed to the region’s mature healthcare infrastructure, rapid adoption of digital health technologies, and substantial investments in mental health research. The presence of leading technology companies, robust regulatory frameworks supporting digital therapeutics, and a high prevalence of mental health disorders further propel market growth. The United States, in particular, benefits from a strong ecosystem of academic research institutions, startup activity, and favorable reimbursement policies, which collectively foster innovation and commercialization of voice biomarker solutions. Strategic collaborations between healthcare providers, technology firms, and research institutes are also accelerating the integration of voice biomarkers into routine clinical practice across North America.

The Asia Pacific region is projected to be the fastest-growing market, with a forecasted CAGR of 22.3% from 2024 to 2033. This impressive growth trajectory is driven by increasing healthcare digitization, rising awareness of mental health issues, and substantial government investments in AI-driven healthcare solutions. Countries such as China, Japan, South Korea, and India are witnessing a surge in pilot programs and research initiatives aimed at leveraging voice biomarkers for early detection and monitoring of mental health disorders. Additionally, the expanding base of tech-savvy populations and the proliferation of smartphones are facilitating the deployment of voice-enabled mental health applications. The region is also benefiting from growing venture capital funding and strategic partnerships between local startups and global technology leaders, which are accelerating product development and market penetration.

Emerging economies in Latin America, the Middle East, and Africa are gradually embracing voice biomarker technologies, albeit at a slower pace due to infrastructural and regulatory challenges. In these regions, mental health stigma, limited access to advanced healthcare services, and budgetary constraints hinder widespread adoption. However, localized demand is rising as policymakers recognize the potential of digital health tools to bridge gaps in mental health care delivery. Pilot projects and collaborations with international organizations are helping to build awareness and demonstrate the value of voice biomarkers. Over time, improvements in digital infrastructure and targeted policy interventions are expected to unlock significant growth opportunities, particularly as these regions seek scalable, cost-effective solutions to address unmet mental health needs.

Report Scope

한국 불안장애 및 우울증 시장은 2025에서 2034 사이 3.80%의 연평균 성장률(CAGR)로 성장할 것으로 예상됩니다. 유니세프와 방탄소년단의 '러브 마이셀프 캠페인' 협업, 코로나19 및 락다운이 한국 산업의 성장을 크게 촉진할 것으로 예상됩니다.

Snapshot img

Female Sexual Dysfunction Treatment Market Size 2025-2029

The female sexual dysfunction treatment market size is forecast to increase by USD 42.82 billion at a CAGR of 62.2% between 2024 and 2029.

The Female Sexual Dysfunction (FSD) treatment market is experiencing significant growth due to the increasing prevalence of chronic diseases, and the resulting impact on women's sexual health. According to various studies, approximately 43% of women experience some form of sexual dysfunction, with conditions such as hypoactive sexual desire disorder, orgasmic disorder, and sexual arousal disorder being common. This trend is further fueled by the increasing awareness and acceptance of sexual health issues among women and the growing research and development in this area. However, the market is not without challenges. One major challenge is the adverse effects of drugs used in FSD treatment.
Many medications used to treat sexual dysfunction in women can cause side effects such as headaches, dizziness, and nausea, which can limit their use and patient compliance. Additionally, the high cost of treatment and the lack of insurance coverage for FSD treatments are significant barriers to market growth. Despite these challenges, the market presents significant opportunities for companies developing effective, safe, and affordable treatments for FSD. Companies that can address these challenges and provide innovative solutions will be well-positioned to capitalize on the growing demand for FSD treatments and meet the unmet needs of women suffering from sexual dysfunction.

What will be the Size of the Female Sexual Dysfunction Treatment Market during the forecast period?

Request Free Sample

The market encompasses a range of disorders that impact sexual desire, response, and satisfaction. Chronic disorders such as diabetes, cardiovascular disease, and depression are significant contributors to this market. Hormonal changes during menopause and gynecological disorders also play a role. Stress and anxiety, interpersonal difficulties, and psychotherapy are additional factors influencing the market's growth. Healthcare organizations are increasingly focusing on addressing female sexual health issues, leading to a swell in demand for treatments. Pharmacological interventions, including medications like phosphodiesterase inhibitors and hormonal therapy, are common treatments.
Non-pharmacological approaches, such as pelvic floor exercises and psychotherapy, are also gaining popularity. Estrogen concentrations and estrogen receptor modulators are used to treat certain sexual dysfunctions. The market is expected to grow due to the increasing awareness of sexual health and the availability of effective treatments for chronic diseases and hormonal imbalances.

How is this Female Sexual Dysfunction Treatment Industry segmented?

The female sexual dysfunction treatment industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Age Group

  Above 40 years
  Below 40 years


Product

  Non-hormonal therapy
  Hormonal therapy


Route Of Administration

  Oral
  Parenteral
  Topical


Distribution Channel

  Hospital pharmacies
  Drug stores and retail pharmacies
  Online pharmacies


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Age Group Insights

The above 40 years segment is estimated to witness significant growth during the forecast period. The market is experiencing notable growth, particularly in the over-40 age demographic. This expansion is driven by the increasing prevalence of chronic conditions such as cardiovascular diseases, diabetes mellitus, and malignant diseases among older women. For instance, in India, cardiovascular diseases affected approximately 63 million women in 2024. Similarly, in the UK and the US, around 55,000 and 30%, respectively, of new female cancers diagnosed in 2024 were breast cancer cases. Several treatment options are available for female sexual dysfunction, including hormonal therapy (such as Ospemifene for dyspareunia), topical treatments (like estrogen creams and vaginal tablets), and pharmacological interventions (such as PDE5 inhibitors and bremelanotide).

Healthcare professionals in specialist clinics, telemedicine services, and research centers provide high-quality care for women dealing with these sexual health issues. Additionally, non-pharmacological therapies, such as acupuncture, pelvic floor exercises, and lifestyle modifications, are gaining popularity. Chronic disorders like chronic pain, stress, and anxiety can be addressed through psychotherapy, sex therapists, and couples therapy. Moder

Snapshot img

South Korea Chocolate Market Size 2024-2028

The South Korea chocolate market size is forecast to increase by USD 155.52 million at a CAGR of 4.39% between 2023 and 2028.

The market is experiencing significant growth, driven by various trends and factors. One key trend is the increasing focus on health benefits, with consumers seeking chocolate that contains vital minerals such as zinc, magnesium, phosphorus, copper, and iron. This demand is fueled by the recognition of chocolate's potential role in addressing health issues like heart disease and mental illnesses, including depression, anxiety, and stress. Another trend is the rise of premiumization, with consumers willing to pay more for high-quality chocolate products. Milk chocolate and white chocolate continue to be popular choices, while cocoa powder is also gaining traction as a versatile ingredient. However, the market is also facing challenges, including growing health concerns related to sugar content and the increasing demand for plant-based and vegan chocolate options. To stay competitive, companies must innovate and adapt to these changing consumer preferences and trends.

What will be the size of the market during the forecast period?

Request Free Sample

Dark chocolate, a popular confectionery item, has gained considerable attention in South Korea for its potential health benefits. The global population's increasing focus on preventive healthcare and the desire for mood enhancement has contributed to the rising demand for this indulgent treat. Dark chocolate is known to contain essential minerals such as magnesium, zinc, and selenium, which contribute to improved heart health. This trend can be attributed to the growing awareness of the health benefits of dark chocolate and the increasing preference for vegan, organic, and gluten-free options. The distribution channels for dark chocolate in South Korea include online platforms and traditional retail outlets such as supermarkets and hypermarkets.

The health benefits of dark chocolate extend beyond cardiovascular health. Consuming dark chocolate can help regulate stress hormones like cortisol. The serotonin and endorphins present in dark chocolate can help alleviate feelings of stress and improve mood. Dark chocolate consumption has also been linked to the prevention and management of certain health conditions. For instance, it can help prevent depression and anxiety, as per various studies. Moreover, it can help address calcium deficiency and caffeine intolerance, making it an attractive option for vegan and organic consumers. The market has been witnessing significant growth, with consumers increasingly preferring this indulgent treat over milk chocolate and carob confectionery. With continued innovation and consumer education, the demand for dark chocolate in South Korea is expected to remain strong.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Dark chocolate
  Milk/white chocolate


Distribution Channel

  Offline
  Online


Product Type

  Molded chocolate
  Softlines/selflines
  Boxed assortments
  Seasonal chocolates
  Others


Geography

  South Korea

By Product Insights

The dark chocolate segment is estimated to witness significant growth during the forecast period.

The milk chocolate segment holds a significant share due to its widespread popularity among consumers. Milk chocolate is made with milk powder, sugar, and cocoa solids, resulting in a milder flavor profile and creamier texture compared to dark chocolate. Milk chocolate bars are a favorite among consumers, offering a delightful taste and enjoyable experience. However, the demand for dark chocolate is on the rise in South Korea, driven by its potential health benefits and unique flavor profile. Dark chocolate is produced by fermenting, roasting, and grinding cocoa beans to create cocoa mass, which is then combined with cocoa butter and a minimal amount of sugar.

Furthermore, the higher percentage of cocoa solids in dark chocolate contributes to its rich, complex flavor and antioxidant properties. Dark chocolate truffles and liquid chocolate are also gaining traction in the South Korean market, catering to consumers seeking a more intense chocolate experience. The growing awareness of the potential health benefits associated with dark chocolate, such as improved heart health and antioxidant properties, has contributed to its increasing popularity. As consumers continue to explore the world of chocolate, the demand for dark chocolate is expected to remain strong in South Korea. In conclusion, the market is diverse, with both milk and dark chocolate catering to different consumer prefer

Gamma Aminobutyric Acid (GABA) Market Outlook

The global Gamma Aminobutyric Acid (GABA) market size was valued at approximately USD 1.2 billion in 2023 and is expected to reach around USD 2.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period. The market is primarily driven by the increasing awareness of the health benefits associated with GABA, a neurotransmitter that plays a crucial role in reducing neuronal excitability throughout the nervous system.

One of the major growth factors of the GABA market is the rising consumer inclination toward mental health and well-being. With increasing levels of stress and anxiety worldwide, consumers are actively seeking natural and effective remedies. GABA, known for its calming effects, has gained significant traction in both the pharmaceutical and dietary supplement sectors. Companies are investing heavily in research and development to innovate new GABA-based products that can cater to the burgeoning demand for mental health solutions.

Another key driver for market growth is the expanding application of GABA in the food and beverage industry. Functional foods and beverages enriched with GABA are gaining popularity among health-conscious consumers. The trend towards fortifying everyday consumables with health-enhancing ingredients has created a lucrative opportunity for GABA. This is evidenced by the proliferation of GABA-infused products such as teas, chocolates, and beverages that claim to offer relaxation and stress relief, thus boosting market growth.

The pharmaceutical industry's growing interest in GABA also propels market expansion. GABA is being extensively researched for its potential therapeutic benefits in treating various neurological and psychiatric disorders such as epilepsy, anxiety, and depression. Pharmaceutical companies are focusing on developing GABA-based medications as alternative or complementary treatments to existing therapies. The increasing prevalence of these conditions and the need for more effective treatments further fuel the demand for GABA in the pharmaceutical sector.

Aminobutryic Acid, a key component of GABA, plays a pivotal role in the modulation of neurotransmission in the brain. This compound is essential for maintaining the balance between excitatory and inhibitory signals, which is crucial for optimal brain function. The presence of Aminobutryic Acid in GABA supplements enhances their efficacy in promoting relaxation and reducing stress. As research continues to explore the benefits of Aminobutryic Acid, its potential applications in treating neurological disorders are becoming increasingly recognized. This has led to a surge in interest from both consumers and healthcare professionals, further driving the demand for GABA-based products.

Regionally, Asia Pacific is anticipated to dominate the GABA market due to the high prevalence of stress-related disorders and the traditional use of GABA in natural remedies. Countries like Japan, China, and South Korea lead in both the production and consumption of GABA. The growing health awareness and increasing disposable income in these regions are significant factors contributing to market growth. Additionally, North America and Europe are also expected to see substantial growth due to the escalating demand for dietary supplements and functional foods.

Product Type Analysis

The Gamma Aminobutyric Acid (GABA) market can be segmented into two primary product types: Synthetic GABA and Natural GABA. Synthetic GABA, being chemically synthesized, offers a consistent and controlled quality, making it highly preferred in pharmaceutical applications. The growing need for high-quality GABA in the development of medications for neurological and psychiatric disorders is a significant factor driving the demand for synthetic GABA. Its consistent quality and availability ensure that pharmaceutical formulations meet stringent regulatory standards.

Natural GABA, derived from plant-based sources or through fermentation processes, is increasingly gaining popularity due to the consumer shift towards natural and organic products. The burgeoning trend of clean-label products, where consumers seek transparency and natural ingredients, has significantly boosted the demand for natural GABA. The food and beverage sector, in particular, has seen a surge in the use of natural GABA in functional foods and beverages aimed at stress relief and relaxation.

Nitrogen Cryotherapy Chamber Market Outlook

The global nitrogen cryotherapy chamber market size was valued at approximately USD 180 million in 2023 and is projected to reach about USD 370 million by 2032, at a CAGR of 8.5% during the forecast period. The market growth is driven by increasing applications in sports, healthcare, and beauty sectors, as well as rising awareness of the benefits of cryotherapy in recovery and wellness.

The growing awareness about the therapeutic benefits of cryotherapy is one of the primary growth factors for the nitrogen cryotherapy chamber market. Cryotherapy is known to reduce inflammation, pain, and muscle soreness, making it popular among athletes and fitness enthusiasts. As more studies support its efficacy, healthcare providers are increasingly recommending cryotherapy for various conditions such as arthritis, chronic pain, and even mental health issues like anxiety and depression. The rising prevalence of chronic conditions and the need for non-invasive treatment options are likely to fuel market growth further.

The sports and fitness industry has significantly contributed to the adoption of nitrogen cryotherapy chambers. Professional athletes and fitness enthusiasts are turning to cryotherapy for quicker muscle recovery and enhanced performance. Sports teams and training facilities are increasingly investing in cryotherapy technology to provide their athletes with the best recovery tools. This trend is expected to continue as the emphasis on athletic performance and recovery intensifies. Additionally, the endorsement of cryotherapy by high-profile athletes and celebrities has spurred public interest, further boosting market growth.

In the beauty and wellness sector, nitrogen cryotherapy chambers are gaining popularity for their anti-aging and skin rejuvenation benefits. Cryotherapy facials and body treatments are becoming a staple in luxury wellness centers and spas. These treatments are marketed as quick and effective solutions for tightening the skin, reducing wrinkles, and improving overall skin tone. As consumers become more beauty-conscious and willing to spend on premium wellness treatments, the demand for cryotherapy services is expected to rise, contributing to market expansion.

Whole Body Cryo therapy is becoming increasingly popular as a holistic approach to health and wellness. This method involves exposing the entire body to extremely cold temperatures, which can help reduce inflammation, improve circulation, and boost overall energy levels. Athletes and fitness enthusiasts often turn to whole body cryo for its potential to enhance muscle recovery and performance. Additionally, this therapy is gaining traction in the wellness sector, where it is valued for its potential to improve mental clarity and mood. As more people seek out non-invasive and natural treatments, the demand for whole body cryo is expected to rise, contributing to the growth of the nitrogen cryotherapy chamber market.

Regionally, the nitrogen cryotherapy chamber market is seeing significant growth in North America and Europe, driven by the high adoption rate and advanced healthcare infrastructure. In North America, the U.S. is a key market due to its large population of athletes and fitness enthusiasts, as well as the availability of advanced medical facilities. Europe follows closely, with countries like Germany, the U.K., and France showing a high uptake of cryotherapy technology. The Asia Pacific region is also emerging as a promising market, with increasing investments in healthcare and wellness sectors, particularly in countries like China, Japan, and South Korea.

Product Type Analysis

When analyzing the nitrogen cryotherapy chamber market by product type, the market is primarily segmented into whole body cryotherapy chambers and partial body cryotherapy chambers. Whole body cryotherapy chambers are designed to expose the entire body to extremely low temperatures for a brief period, typically three minutes. These chambers are gaining traction, particularly in sports and wellness settings, due to their comprehensive treatment approach. The growing demand for holistic wellness solutions and the increasing adoption in medical rehabilitation centers are driving the market for whole body cryotherapy chambers.

Partial body cryotherapy chambers, on the other hand, focus on exposing only a part of the body, usually from the neck down, to extreme cold. These chambers are often used for local

Snapshot img

Finger Millet Market Size 2024-2028

The finger millet market size is forecast to increase by USD 5.21 billion at a CAGR of 6.78% between 2023 and 2028.

Finger millet, a nutrient-dense crop known for its low glycemic index, offers significant opportunities in the health food industry. The key driver for the market is its property of aiding diabetes control, making it an attractive option for consumers seeking healthier alternatives. However, the market faces challenges, primarily due to the shortage of millet processing units. This scarcity hinders the production capacity expansion and limits the market's growth potential. Companies looking to capitalize on this market can explore partnerships with processing unit providers or invest in setting up their own facilities to address the processing bottleneck.
Additionally, focusing on research and development to create value-added products, such as flour or flakes, can cater to the growing demand for finger millet in various applications. By addressing these challenges, market players can effectively tap into the potential of the market and cater to the increasing consumer preference for healthier food options.

What will be the Size of the Finger Millet Market during the forecast period?

Request Free Sample

Finger millet, a nutrient-dense ancient grain, continues to gain traction in various sectors due to its unique properties and evolving market dynamics. From traceability to innovation, the market exhibits a dynamic and continuous nature. Finger millet's traceability is increasingly important as consumers demand transparency and sustainability. This has led to advancements in distribution channels, ensuring a reliable supply of high-quality finger millet to retailers and end consumers. In the retail sector, finger millet's versatility is showcased through various applications, such as pasta, beverages, and baked goods. The nutritional benefits of finger millet, including its high iron content and gluten-free status, have fueled its growth in the health food market.
Standards and certifications play a crucial role in maintaining consistency and credibility, ensuring consumer trust. Finger millet's potential as a functional ingredient in various food and beverage applications continues to unfold, with ongoing research and innovation driving new product development. Finger millet's cultivation and processing techniques are continually evolving to improve yield and quality, with a focus on precision agriculture practices and hybrid varieties. The grain's fiber content and antioxidant properties make it an attractive option for both food and beverage industries. As consumer preferences shift towards healthier, more sustainable options, the market is poised for continued growth and innovation.

How is this Finger Millet Industry segmented?

The finger millet industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Food source
  Fodder
  Baking


Distribution Channel

  Supermarkets
  Online Retail
  Direct Sales
  Distributors


Category Type

  Food & Beverage
  Animal Feed
  Pharmaceuticals


Product Types

  Whole Grain
  Flour
  Processed Foods


End-User

  Household
  Commercial
  Industrial


Geography

  North America

    US
    Mexico


  Europe

    France
    Germany
    Italy
    Spain
    UK


  Middle East and Africa

    UAE


  APAC

    Australia
    China
    India
    Japan
    South Korea


  South America

    Brazil


  Rest of World (ROW)

By Application Insights

The food source segment is estimated to witness significant growth during the forecast period.

Finger millet, a nutrient-dense grain, is gaining popularity in the global food industry due to its numerous health benefits. Rich in iron and calcium, finger millet is commonly used to alleviate health conditions such as anemia and aid in managing depression, insomnia, and anxiety. Finger millet's hypoglycemic noodles, made from its flour, have a low glycemic index, making them an ideal food for individuals with blood sugar concerns. The cultivation of finger millet is prevalent in various parts of India, where it is used to make traditional dishes like dosa, murukku, and chapati. Finger millet's amino acid content helps regulate appetite, contributing to weight management.

The market for finger millet is projected to expand due to its potential health benefits in addressing conditions like high blood pressure, liver and heart problems, and asthma. The finger millet value chain encompasses cultivation, processing, packaging, distribution, and retail. Processing includes milling, baking, and creating various products like porridge, beverages, pasta, and snacks. Regulations play a crucial role